Flávia De Angelis

机构：Université de Sherbrooke

发表论文 17 篇 · 总被引 10407 次 · h-index 9

代表论文

• Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer (2018 · New England Journal of Medicine · 被引 6752)
• Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial (2019 · The Lancet · 被引 3385)
• Potential role of immunosenescence in cancer development (2010 · Annals of the New York Academy of Sciences · 被引 161)
• Abstract CT043: Outcomes among patients (pts) with metastatic nonsquamous NSCLC with liver metastases or brain metastases treated with pembrolizumab (pembro) plus pemetrexed-platinum: Results from the KEYNOTE-189 study (2019 · Cancer Research · 被引 23)
• Paraneoplastic neurologic syndromes: Clinical presentation and management (2014 · Current Problems in Cancer · 被引 20)
• Health-related quality of life (HRQoL) in the KEYNOTE-189 study of pembrolizumab (pembro) or placebo (pbo) + pemetrexed (pem) + platinum (plt) for metastatic NSCLC. (2018 · Journal of Clinical Oncology · 被引 16)